OO

Oncode Oncology Bridge Fund

Description

The Oncode Oncology Bridge Fund provides early stage financing to help the creation and growth of new enterprises

Investor Profile

Oncode Oncology Bridge Fund has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in The Netherlands.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Series A (100%)

Country Focus

  • The Netherlands (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Oncode Oncology Bridge Fund frequently co-invest with?

Curie Capital
North America, Missouri, United States, Netherlands
Co-Investments: 1
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Co-Investments: 1
Qbic Fund
North America, Wisconsin, United States, Belgium
Co-Investments: 1
Swanbridge Capital
Europe, Zuid-Holland, The Netherlands, Rotterdam
Co-Investments: 1
BOM
Europe, Noord-Brabant, The Netherlands, Tilburg
Co-Investments: 1
V-Bio Ventures
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 1

What are some of recent deals done by Oncode Oncology Bridge Fund?

Cyclomics

Utrecht, Utrecht, The Netherlands

Cyclomics is a Dutch startup with ambition is to transform cancer care by enabling faster and more reliable diagnoses.

Health CareOncology
Series UnknownJan 7, 2026
Amount Raised: $3,038,789
Laigo Bio

Utrecht, Utrecht, The Netherlands

Laigo Bio uses E3 ligase internalization to precisely degrade membrane proteins linked to autoimmune and inflammatory disorders.

BiotechnologyMedical
SeedDec 3, 2025
Amount Raised: $13,406,842
Flindr Therapeutics

Amsterdam, Noord-Holland, The Netherlands

Flindr Therapeutics, a private biotech company develops next-generation precision oncology treatments.

BiotechnologyHealth CareTherapeutics
Series AApr 24, 2024
Amount Raised: $21,400,056

Find More Investors Like Oncode Oncology Bridge Fund

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides